Raymond James Financial Services Advisors’s Twist Bioscience TWST Stock Holding History

Raymond James Financial Services Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-68,328	Closed	-$3.37M	–	3562
2024 Q2	$3.37M	Buy	+68,328	New	+$2.79M	﹤0.01%	1373
2021 Q3	–	Sell	-1,550	Closed	-$207K	–	3417
2021 Q2	$207K	Sell	1,550 -2,697	-64%	-$314K	﹤0.01%	2997
2021 Q1	$526K	Buy	4,247 +1,356	+47%	+$206K	﹤0.01%	2250
2020 Q4	$408K	Buy	+2,891	New	+$321K	﹤0.01%	2272

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James Financial Services Advisors's TWST Position: Q3 2024 in Review

Raymond James Financial Services Advisors sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 68,328 shares — an estimated $3.37M sold.

Raymond James Financial Services Advisors first reported a position in TWST in Q4 2020 and held it in 4 quarters. The position peaked at $3.37M in Q2 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

Raymond James Financial Services Advisors reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
Raymond James Financial Services Advisors sold 68,328 Twist Bioscience shares in Q3 2024, an estimated $3.37M.
Raymond James Financial Services Advisors first reported a position in Twist Bioscience in Q4 2020 and held it in 4 quarters.
Raymond James Financial Services Advisors's Twist Bioscience position peaked at $3.37M in Q2 2024.
246 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.